Autoantibodies to Citrullinated (Poly)Peptides: A Key Diagnostic and Prognostic Marker for Rheumatoid Arthritis
- 1 June 2004
- journal article
- review article
- Published by Taylor & Francis in Autoimmunity
- Vol. 37 (4) , 295-299
- https://doi.org/10.1080/08916930410001708733
Abstract
(2004). Autoantibodies to Citrullinated (Poly)Peptides: A Key Diagnostic and Prognostic Marker for Rheumatoid Arthritis. Autoimmunity: Vol. 37, No. 4, pp. 295-299.Keywords
This publication has 29 references indexed in Scilit:
- Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)Annals of the Rheumatic Diseases, 2004
- Evaluation of anti-citrullinated filaggrin antibodies as hallmarks for the diagnosis of rheumatic diseasesAnnals of the Rheumatic Diseases, 2004
- Therapeutic strategies for rheumatoid arthritisNature Reviews Drug Discovery, 2003
- Autoantibodies can be prognostic markers of an erosive disease in early rheumatoid arthritisAnnals of the Rheumatic Diseases, 2003
- Filaggrin related antibodies among the agedAnnals of the Rheumatic Diseases, 2003
- Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.Journal of Clinical Investigation, 1998
- Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin.Annals of the Rheumatic Diseases, 1991
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Anti-keratin antibodies in rheumatoid arthritis.BMJ, 1979
- New Serum Factor in Patients with Rheumatoid Arthritis: The Antiperinuclear FactorAnnals of the Rheumatic Diseases, 1964